CD22

Engineered Antibody Glyco-Abs

Predicted to enable CD4 receptor binding activity; protein phosphatase binding activity; and sialic acid binding activity. Involved in B cell activation; negative regulation of B cell receptor signaling pathway; and regulation of endocytosis. Located in early endosome and recycling endosome.

Recombinant Anti-Human CD22 Antibody (Fc glycosylation) (Gly-111LC)
- Host Species: Human
- Specificity: Human
- Type: Chimeric antibody (mouse/human)
- Glycosylation site: Asn297 in Fc region

Recombinant Anti-Human CD22 Antibody (Fab glycosylation) (Gly-001LC)
- Host Species: Mouse
- Specificity: Human
- Type: Mouse antibody
- Glycosylation site: FR1 of VK

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.

Cart

Inquiry